| الاسم العلمي | الشكل الصيدلاني | التركيز |
|---|---|---|
Attenuated Infectious Bursal Disease Virus S706 strain |
Lyophilisate for suspension |
NLT 4.0- |
Marek Disease Virus Serotype 1/ Marek Disease Virus Serotype 3 |
Suspension for injection |
NLT 836- , NLT 1,414- |
Marek Disease vectored IBD recombinant virus |
Suspension for injection |
NLT 3,880d |
Streptococcus iniae antigin |
Suspension for injection |
1×10^10cells/ml |
Mareks Disease Rispens CVI988 Strain |
Suspension for injection |
1608PFU/dose |
Newcastle disease virus LaSota strain |
Suspension for use in drinking water |
5.5 log10EID50/dose |
Inactivated NDV strain NDV-SZ LaSota/ Inactivated IBV strain M-41/ Inactivated EDS strain B8-78 |
Emulsion for injection |
4 log HItitre , 6 log HItitre , 7 log HItitre |
Mycoplasma agalactiae strain N 262 inactivated |
Emulsion for injection |
=2mm |
Cl sordellii toxoid/Cl chauvoei anaculture/Cl perfringens Type A toxoid/Cl perfringens Type C toxoid/ Cl perfringens Type D toxoid/Cl septicum toxoid/Cl novyi Type B toxoid |
Suspension for injection |
2000i.u. , 7×10^8i.u. , 12i.u. , 33i.u. , 100i.u. , 7i.u. , 1000i.u. |
Staphylococcus aureus inactivated expressing Biofilm strain SP 140 |
Emulsion for injection |
8.98 log10ml |